Author:
Smeets M,Raymakers R,Muus P,Vierwinden G,Linssen P,Masereeuw R,de Witte T
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference67 articles.
1. Wiernik PH, Dutcher JP . Clinical importance of anthracyclines in the treatment of acute myeloid leukemia Leukemia 1992 6: (Suppl. 1) 67–69
2. Speth PA, Linssen PC, Boezeman JB, Wessels HM, Haanen C . Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion Cancer Chemother Pharmacol 1987 20: 311–315
3. Workman P . Infusional anthracyclines: is slower better? If so, why? Ann Oncol 1992 3: 591–594
4. Hollingshead LM, Faulds D . Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer Drugs 1991 42: 690–719
5. Ames MM, Spreafico E . Selected pharmacologic characteristics of idarubicin and idarubicinol Leukemia 1992 6: (Suppl. 1) 70–75
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献